U.S. Water Utilities Stock News

Penguin Solutions overview after recent rebrand Penguin Solutions (PENG) is drawing fresh attention after its recent name change from SMART Global Holdings, shifting the focus to its enterprise computing, memory, and LED businesses, while the share price has been mixed over the past year. See our latest analysis for Penguin Solutions. Since the rebrand, Penguin Solutions’ share price return has been softer, with a 7 day share price return showing a 4.8% decline and a 90 day share price return...

Plexus (PLXS) opened fiscal Q1 2026 with revenue of US$1.1b and basic EPS of US$1.54, while trailing twelve month basic EPS stood at US$6.56 on revenue of US$4.1b, setting a clear earnings season backdrop for investors. Over the past year, the company has seen revenue move from US$3.96b to US$4.1b on a trailing basis, with basic EPS rising from US$4.08 to US$6.56, giving investors a fuller view of how the latest quarterly print fits within the recent earnings run and margin profile. See our...

Curtiss-Wright recently expanded its defense and aerospace footprint through a collaboration with Green Hills Software on a high-performance, safety-certifiable COTS computing solution for critical avionics, alongside earlier validation of its PacStar tactical edge servers for Azure Local in November 2025. By pairing safety-certifiable avionics computing with cloud-enabled tactical edge servers, Curtiss-Wright is positioning its portfolio at the intersection of mission-critical reliability...

GE Vernova (GEV) closed out FY 2025 with Q4 revenue of US$10.96b and basic EPS of US$13.57, alongside net income excluding extra items of US$3,664m, capping a year in which trailing twelve month EPS reached US$17.96 on revenue of US$38.07b. Over the past six quarters, the company has seen quarterly revenue move from US$8,913m in Q3 2024 to US$10,558m in Q4 2024 and then to US$10,956m in Q4 2025, while basic EPS shifted from a loss of US$0.35 in Q3 2024 to US$1.75 in Q4 2024 and then to...

CG Oncology has been gaining attention as its flagship BOND-003 therapy progresses through phase 3 trials for high-risk BCG-unresponsive non-muscle invasive bladder cancer, aiming to offer a bladder-sparing treatment option. The company’s focus on addressing this difficult-to-treat patient group highlights its potential role in reshaping how bladder cancer is managed if trial outcomes support its approach. Next, we’ll examine how the advanced phase 3 progress of BOND-003 shapes CG Oncology’s...

In recent days, Barclays upgraded PTC Therapeutics to an Overweight rating, while other brokers continued to rate the biotech as Outperform, underscoring growing analyst optimism around the company’s rare disease portfolio. This convergence of positive views, anchored in PTC’s therapies for conditions such as Duchenne muscular dystrophy and AADC deficiency, highlights how analyst sentiment can crystallize around a focused clinical pipeline. Next, we’ll examine how this strengthened analyst...

Medical Properties Trust (NYSE:MPW) has relocated its corporate headquarters to a new address in Alabama. The move marks an official change in the company’s primary base of operations. Medical Properties Trust focuses on investing in hospital and healthcare facilities, with tenants that operate across a range of medical services. A headquarters relocation can affect how leadership is organized, how teams work together and how resources are allocated across the portfolio. For you as an...

POET Technologies (NasdaqCM:POET) has drawn fresh attention after completing a US$150.000006 million registered direct follow on equity offering at US$7.25 per share, issuing 20,689,656 new common shares to investors. See our latest analysis for POET Technologies. The follow on offering and shelf registration have arrived during a weaker patch for the stock, with a 7 day share price return of 14.27% decline and a year to date share price return of 16.90% decline. However, the 1 year total...

L3Harris Technologies (LHX) closed out FY 2025 with fourth quarter revenue of US$5.6b and basic EPS of US$1.60, alongside net income of US$300m, while trailing twelve month EPS stood at US$8.57 on revenue of US$21.9b and net income of US$1.6b. Over the past six quarters, the company has seen quarterly revenue move from US$5.3b in Q3 2024 to US$5.6b in Q4 2025, with basic EPS ranging between US$1.60 and US$2.47 and net income between US$300m and US$462m, setting a clear earnings profile for...

In January 2026, Capital One Financial reported fourth-quarter 2025 results showing net interest income of US$12,466 million and net income of US$2,134 million, alongside net charge-offs rising to US$3,833 million from US$2,884 million a year earlier. The earnings miss versus analyst expectations, coupled with higher credit losses, has already drawn legal scrutiny and prompted revisions to analyst earnings forecasts. Next, we will examine how the earnings miss and rising net charge-offs...

Sherwin-Williams (SHW) has wrapped up FY 2025 with fourth quarter revenue of US$5,595.9 million and basic EPS of US$1.94, alongside trailing twelve month revenue of US$23.6 billion and EPS of US$10.37 that frame the full year earnings picture. Over recent periods, revenue has moved from US$5,297.2 million in Q4 2024 to US$5,595.9 million in Q4 2025, while quarterly EPS has been reported at US$1.92 and US$1.94 respectively, giving investors a clear read on how top line and per share profits...

First Financial Bancorp (FFBC) closed out FY 2025 with fourth quarter revenue of US$228.7 million and EPS of US$0.65. Trailing twelve month revenue was US$861.8 million and EPS was US$2.68. Over the past year, the company’s revenue increased from US$756.1 million to US$861.8 million and EPS moved from US$2.42 to US$2.68. This coincided with earnings growth of 11.7% over the last 12 months, compared with a 5-year average of 6.8% per year. Investors may weigh this growth and a 3.47% dividend...

Apple (AAPL) just delivered a record fiscal first quarter, with iPhone 17 driving all time iPhone revenue, Services posting strong growth, and new AI moves with Google and Q.ai sharpening investor focus. See our latest analysis for Apple. Apple’s latest results and AI announcements come after a choppy start to 2026, with a 7 day share price return of 4.13% but a 30 day share price decline of 5.00%, while the 1 year total shareholder return of 9.94% and 3 year total shareholder return of...

IonQ has entered a definitive agreement to acquire SkyWater Technology (NasdaqCM:SKYT), aiming to build a vertically integrated full stack quantum and semiconductor platform in the United States. The combined company is expected to focus on quantum chip development and manufacturing capabilities for government and commercial customers. Multiple law firms have launched investigations into whether the transaction terms and process are fair to SkyWater shareholders. For you as an investor,...

If you are wondering whether Jabil's share price still offers value, or if most of the opportunity is already reflected in the stock, this article walks through what the numbers indicate about where the price stands today. The stock last closed at US$243.92, with returns of 5.3% over 30 days, 1.5% year to date, 50.2% over 1 year, a gain of about 3x over 3 years, and an even larger gain over 5 years. Recent coverage has focused on Jabil's positioning in electronics manufacturing and supply...

Bloom Energy (BE) is back in focus after an American Electric Power subsidiary exercised a long term offtake option worth roughly US$2.65 billion for its solid oxide fuel cells, tied to rising AI data center power needs. See our latest analysis for Bloom Energy. That contract has arrived after a powerful run in the shares, with a 30 day share price return of 79.36% and a year to date share price return of 58.59%. The 1 year total shareholder return is very large and the 5 year total...

Hawthorn Bancshares (HWBK) has wrapped up FY 2025 with fourth quarter revenue of US$20.8 million and EPS of US$0.90, set against trailing 12‑month revenue of US$79.9 million and EPS of US$3.44 that came with 30.4% earnings growth over the past year. The company has seen revenue move from US$71.9 million and EPS of US$2.61 on a trailing basis a year ago to the latest US$79.9 million and US$3.44, while quarterly revenue has ranged between US$16.7 million and US$20.8 million through 2025. With...

Farmers National Banc (FMNB) is back on investors’ radar after recent share price moves, with the stock closing at $12.85 and showing mixed returns over the past week, month, and past 3 months. See our latest analysis for Farmers National Banc. At a share price of $12.85, Farmers National Banc has seen short term weakness, with a 7 day share price return of a 7.62% decline, while longer term total shareholder returns over three and five years sit at 2.99% and 14.51% respectively. This may...

If you are wondering whether Ionis Pharmaceuticals at US$83.88 is starting to look expensive or still offers value, you are not alone. The stock has returned 2.6% over the last 7 days, 6.2% over 30 days, 5.3% year to date and 151.7% over the past year, with 103.6% over 3 years and 41.2% over 5 years, which will naturally shape how investors think about its risk and return profile. Recent coverage around Ionis has focused on its position in the pharmaceuticals and biotech space, where...

LendingClub (LC) has wrapped up FY 2025 with fourth quarter revenue of US$354.0 million and basic EPS of US$0.36, set against a trailing twelve month EPS of US$1.18 on revenue of about US$1.33 billion. Over the past year, the company has seen revenue move from US$1.16 billion to roughly US$1.33 billion on a trailing basis, while EPS shifted from US$0.46 to US$1.18, alongside earnings growth of 164.3%. Together with higher reported profit margins compared with the prior year, these results...

FormFactor (NasdaqGS:FORM) is facing long term profitability questions as revenue growth has lagged semiconductor peers over the past five years. Earnings per share have weakened over the same period, raising concerns about the company’s ability to translate sales into sustainable profit. Free cash flow margins have deteriorated as FormFactor has committed to heavier investment outlays, increasing financial strain. FormFactor, a provider of semiconductor testing and measurement solutions,...

First Foundation (FFWM) just posted its FY 2025 fourth quarter numbers with total revenue of US$54.9 million and a basic EPS loss of US$0.10, as the bank continues to work through a period of unprofitable results. Over the past year, the company has seen trailing twelve month revenue of US$170.5 million against a basic EPS loss of US$1.88, which sets a clear backdrop of earnings pressure even as top line activity remains meaningful. With margins still under strain, the latest release puts the...

If you are wondering whether Motorola Solutions at around US$403 per share looks expensive or reasonable, it helps to step back and look at what the current price actually reflects about the business. The stock has returned 1.4% over the last 7 days and 5.0% over the last 30 days, while the year to date return sits at 5.8% and the 1 year return is a 13.8% decline, compared with a 62.9% return over 3 years and 135.1% over 5 years. Recent news coverage around Motorola Solutions has focused on...

DexCom (DXCM) is back in focus after Barclays downgraded the stock to Underweight, citing intensifying competition in its core insulin-intensive markets projected for 2026 and 2027, and raising questions about valuation. See our latest analysis for DexCom. At a share price of US$74.0, DexCom has seen a 27.10% 90 day share price return and a 10.35% 30 day share price return. However, its 1 year total shareholder return shows a 15.54% decline, signaling fading longer term momentum even as short...